Japanese pharmaceutical companies are actively exploring the Philippines for possible investments after the conduct of a webinar detailing opportunities in the country.
The webinar was organized by the Board of Investments and the Foreign Trade Service Corps, together with the Kansai Pharmaceutical Industries Association on May 20.
“As we work to ‘Build Back a Better Philippines’, we recognize the importance of our international partners like Japan. With the developments in health insurance schemes, health systems and increasing investments in public health, the Philippines can serve as Japan’s market for pharmaceutical products,” said BOI managing head and Trade Undersecretary Ceferino Rodolfo.
“As our country prepares the local environment and standards through the implementation of ASEAN harmonization and other initiatives for Good Manufacturing Practice, the Philippines can be a good production base for Japanese companies’ pharmaceutical exports. Not to mention, the Philippines is Japan’s closest ASEAN country in terms of geographical proximity,” said Rodolfo.
